Vaxtex Cotfab Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
VCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaxtex Cotfab has filed audited financial results for FY25. Revenue from operations fell sharply to ₹525.33 lakhs from ₹1,662.03 lakhs in FY24, a drop of about 68%. However, the company turned profitable with a profit after tax of ₹88.36 lakhs against a loss of ₹883.40 lakhs in the previous year. Total expenses also dropped significantly from ₹2,589.35 lakhs to ₹597.07 lakhs, helping the bottom line. A key highlight is that the NCLT, Ahmedabad recalled the earlier CIRP (insolvency) order in January 2025, and the company is now fully operational under its Board. The auditor (SSRV & Associates) issued an unmodified opinion. Operating cash flow also turned positive at ₹127.04 lakhs from a negative ₹1,180.88 lakhs last year. Several large related party transactions, including loans and sales to a director-linked entity, were disclosed.
The exit from CIRP and the swing from a large loss to a small profit is a positive operational signal for shareholders. However, the steep revenue decline and substantial related party transactions (notably with Hearmo Tech, linked to the promoter) are concerns that investors should watch closely. The stock may see mixed sentiment as the turnaround story is tempered by weak top-line performance.